10-Q: Phreesia Q3 2025: Net Income Rebound, AccessOne Acquisition

Phreesia reports a significant turnaround to net income in Q3 2025, driven by strong revenue growth across all segments and the strategic acquisition of AccessOne.

Summary

• Total revenue increased 13% to $120.3 million for the three months ended October 31, 2025, compared to $106.8 million in the prior year period.
• Total revenue increased 14% to $353.5 million for the nine months ended October 31, 2025, compared to $310.1 million in the prior year period.
• Net income was $4.3 million for the three months ended October 31, 2025, a significant improvement from a net loss of $14.4 million in the prior year period.
• Net income was $1.0 million for the nine months ended October 31, 2025, compared to a net loss of $52.1 million in the prior year period.
• Adjusted EBITDA increased to $29.1 million for the three months ended October 31, 2025, from $9.8 million in the prior year period.
• Adjusted EBITDA increased to $72.1 million for the nine months ended October 31, 2025, from $20.4 million in the prior year period.
• Net cash provided by operating activities was $15.5 million for the three months ended October 31, 2025, and $45.2 million for the nine months ended October 31, 2025.
• Free cash flow was $8.8 million for the three months ended October 31, 2025, and $25.9 million for the nine months ended October 31, 2025, a turnaround from a negative $0.9 million in the prior year nine-month period.
• Cash and cash equivalents increased by $22.2 million to $106.4 million as of October 31, 2025, from $84.2 million as of January 31, 2025.
• The company completed the acquisition of AccessOne on November 12, 2025, for approximately $160 million in cash, funded by a combination of cash and a new $110 million secured Bridge Loan.
• The average number of healthcare services clients (AHSCs) increased to 4,520 for the three months ended October 31, 2025, from 4,237 in the prior year period.
• Total revenue per AHSC increased 6% to $26,622 for the three months ended October 31, 2025, from $25,207 in the prior year period.
• Patient payment volume increased to $1.181 billion for the three months ended October 31, 2025, from $1.081 billion in the prior year period.
• The payment facilitator volume percentage increased to 85% for the three months ended October 31, 2025, from 81% in the prior year period.

Sentiment

Score: 8

Explanation: The company demonstrated a strong financial turnaround with significant improvements in net income, Adjusted EBITDA, and free cash flow, alongside strategic growth through acquisition. While the Bridge Loan introduces short-term refinancing needs and legal proceedings pose a risk, the overall operational improvements, revenue growth across all segments, and increased Adjusted EBITDA suggest a positive outlook for future performance and shareholder value.

Positives

• Achieved a significant turnaround from net loss to net income for both the three months ($4.3 million) and nine months ($1.0 million) ended October 31, 2025.
• Demonstrated strong revenue growth across all segments: Subscription and related services (+12% Q3, +13% 9M), Payment processing fees (+11% Q3, +11% 9M), and Network solutions (+14% Q3, +18% 9M).
• Reported substantial increases in Adjusted EBITDA, reaching $29.1 million in Q3 2025 and $72.1 million for the nine months ended October 31, 2025.
• Generated positive and significantly increased free cash flow of $8.8 million in Q3 2025 and $25.9 million for the nine months ended October 31, 2025, indicating improved operational efficiency and cash generation.
• Successfully completed the strategic acquisition of AccessOne on November 12, 2025, expanding financing solutions for healthcare receivables.
• Maintained compliance with all covenants related to the Capital One Credit Facility as of October 31, 2025.
• Recognized a discrete tax benefit of $2.22 million during the nine months ended October 31, 2025, primarily related to Canadian deferred tax assets.

Negatives

• Incurred approximately $3 million in debt issuance costs and original issue discount related to the new $110 million Bridge Loan for the AccessOne acquisition.
• The Bridge Loan has an escalating interest rate (increasing by 0.5% every three months) and a short maturity date of November 11, 2026, necessitating refinancing efforts.
• Facing ongoing legal proceedings, including 14 putative class action complaints, related to a 2024 cybersecurity incident impacting the ConnectOnCall service, with potential for substantial damages and legal expenses.
• The allowance for doubtful accounts increased to $2.175 million as of October 31, 2025, from $1.468 million as of January 31, 2025.
• Historically incurred significant operating losses and may incur net losses in the future, despite recent improvements.
• Relies on a limited number of clients for a substantial portion of total revenue and accounts receivable, posing concentration risk.
• Operating as a fully remote company introduces unique operational risks, including potential cybersecurity vulnerabilities and challenges in maintaining corporate culture.
• Exposure to foreign currency exchange risk due to operations in Canada and India, which could adversely affect operating results.
• Subject to various macroeconomic and geopolitical risks, including inflation, interest rate changes, and global conflicts, which could impact business operations and financial performance.

Risks

• Operating in a highly competitive industry, including competition from EHR and PM systems, which could harm business and results of operations.
• Failure to manage future growth effectively could prevent revenue increase and hinder business strategy implementation.
• Operating results may fluctuate significantly, and failure to meet analyst or investor expectations could lead to a substantial decline in stock price.
• Privacy concerns, cyber-attacks, data breaches, or cybersecurity incidents could result in economic loss, damage to reputation, deterring users, and exposure to legal penalties and liability.
• Operations in India subject the company to additional risks, including increasing wages, competition for talent, political/economic instability, and foreign currency fluctuations.
• Incurring significant upfront costs in client relationships, with no assurance of recovering these costs if relationships do not develop or grow over time.
• Variable sales and implementation cycles may lead to delays in revenue recognition and fluctuations in quarterly results of operations.
• Estimates and assumptions used to determine the size of the target market may prove inaccurate, and business may not grow at similar rates.
• Dependence on the senior management team and certain key employees; loss or inability to attract and retain highly skilled employees could adversely affect the business.
• Acquisitions and investments, including the AccessOne Acquisition, may be difficult to integrate, divert management resources, result in unanticipated costs, or dilute stockholders.
• Inability to successfully integrate the AccessOne business, leading to higher costs, longer integration times, or failure to realize anticipated benefits.
• Uncertainty regarding the sufficiency of cash from operations and available borrowing capacity to satisfy obligations under the Bridge Loan, and potential inability to obtain long-term financing on favorable terms.
• Being a fully remote company subjects the company to unique operational risks, including cybersecurity and maintaining corporate culture.
• Subject to complex healthcare laws and data privacy and security laws and regulations (e.g., HIPAA, GLBA, NYDFS Part 500, CCPA, CPRA, My Health My Data Act, GDPR, PIPEDA, CASL), which may impose restrictions, require business practice changes, and expose the company to fines, penalties, and lawsuits.
• Artificial intelligence (AI) presents risks and challenges, including security risks to confidential information, increased regulatory and compliance burden, and increased competition.
• Reliance on third-party contractors, vendors, and partners, including some outside the United States, where replacing them could be difficult and disruptive.
• If the payments platform is limited, restricted, curtailed, or degraded, or if it fails to continue to grow and develop, the business may be materially and adversely affected.
• Increases in card network fees and other changes to fee arrangements may result in the loss of clients or a reduction in earnings.
• Failure to comply with applicable requirements of card networks could lead to fines, suspension, or termination of payment facilitator status.
• Changes in laws and regulations relating to interchange fees on payment card transactions (e.g., Durbin Amendment) would adversely affect revenue and results of operations.
• Inadequate protection of intellectual property could prevent name recognition, technology, and product protection, adversely affecting the business.
• Restrictions on the use of, or ability to license and integrate, third-party technologies could have a material adverse effect.
• Third parties may initiate legal proceedings alleging intellectual property infringement, leading to uncertain outcomes and adverse effects.
• Interruption or failure of information technology and communications systems could impair service delivery, leading to client loss and harm to operating results.
• Liability for use of incorrect or incomplete data provided, which could harm business, financial condition, and results of operations.
• Use of open source software could adversely affect the ability to offer services and subject the company to possible litigation.
• Risks related to government contracts and related procurement regulations.
• The U.S. Food and Drug Administration (FDA) may in the future determine that technology solutions are subject to the Federal Food, Drug, and Cosmetic Act, leading to additional costs and risks.
• Potential claims that calling or text messaging services are subject to, and not compliant with, the Telephone Consumer Protection Act (TCPA) or similar state laws.
• Adverse effects from the operation of laws in non-U.S. jurisdictions (Canada, India).
• Subject to additional government regulation, including consumer lending regulation (AccessOne MedCard), Foreign Corrupt Practices Act (FCPA) and foreign anti-bribery laws, and economic sanctions and export controls.
• Reliance on a limited number of third-party suppliers and contract manufacturers, with potential for negative effects from loss or degradation of performance.
• Reliance on Internet infrastructure, bandwidth providers, data center providers, and other third parties, with potential for failures or interruptions.
• Financial results are based on estimates and judgments; changes in related judgments, assumptions, accounting standards, or tax regulations could materially impact financial position and results of operations.
• Ability to use net operating losses (NOLs) to offset future taxable income may be subject to certain limitations under Section 382 of the Internal Revenue Code.
• The Bridge Loan, net of any prepayments, will become payable in full at maturity on November 11, 2026, with no assurance that cash from operations and available borrowing capacity will be sufficient, or that long-term financing will be obtained on favorable terms.
• Cash and cash equivalents could be adversely affected if the financial institutions in which they are held fail.
• Need to incur additional indebtedness or seek capital through new equity or debt financings, which may not be available on acceptable terms or at all, leading to dilution or restrictive covenants.
• Restrictive covenants in the agreements governing the Capital One Credit Facility and the Bridge Loan may restrict the ability to pursue business strategies.
• Adverse developments affecting the financial services industry could adversely affect current and projected business operations and financial condition.
• The company's share price has been and may in the future be volatile, potentially leading to loss of investment.
• No current intention to pay dividends on common stock, meaning return on investment depends on stock price appreciation.
• The stock repurchase program may not enhance long-term stockholder value, could increase stock price volatility, and diminish cash reserves.
• Anti-takeover provisions under incorporation documents and Delaware law could delay or prevent a change of control.
• Bylaws designate certain specified courts as the sole and exclusive forums for certain disputes, potentially limiting stockholders' ability to obtain a favorable judicial forum.

Future Outlook

The company expects to refinance or replace the Bridge Loan with a long-term credit facility before its maturity on November 11, 2026. Management believes that current cash and cash equivalents, along with cash generated from normal operations and available borrowing capacity under the Capital One Credit Facility, will be sufficient to meet the company's needs for at least the next 12 months. Future capital requirements and the adequacy of available funds will depend on various factors, including the need to finance working capital, develop technological infrastructure, fund strategic relationships, and potentially acquire complementary businesses and technologies.

Management Comments

• "Phreesia's mission is to make care easier every day."
• "Management believes that the Company's cash and cash equivalents, along with cash generated in its normal operations and the available borrowing capacity under the Capital One Credit Facility will be sufficient to meet the Company's needs for at least the next 12 months."
• "We intend to refinance or replace the Bridge Loan with a long-term credit facility."

Industry Context

The company operates in a fragmented and highly competitive healthcare technology market, characterized by rapidly evolving technology standards, regulatory requirements, and client needs, including the increasing adoption of AI technologies. Demand for its products and services is significantly driven by increasing patient responsibility, engagement, and consumerism in healthcare. The industry is also experiencing heightened scrutiny of medical debt and charity care thresholds, which could impact patient payment volumes. Furthermore, macroeconomic conditions such as inflation and interest rate changes, along with geopolitical uncertainties, continue to influence the broader healthcare and financial markets.

Corporate Governance

Legal Proceedings

• 14 putative class action complaints were filed against ConnectOnCall.com, LLC and Phreesia, Inc., consolidated as In re ConnectOnCall.com Data Breach Litigation, in the United States District Court for the Eastern District of New York.
• Plaintiffs allege personally identifiable information and personal health information were stolen due to a cybersecurity incident impacting the ConnectOnCall service in 2024.
• Claims include common law claims seeking monetary damages, disgorgement, restitution, attorneys' fees, interest, declaratory relief, and injunctive relief.
• The company expects to incur legal and professional services expenses associated with this litigation, net of probable insurance recoveries.
• A range of possible losses cannot be reasonably estimated at this time due to the early stages of the proceedings, unspecified damages, and uncertainty regarding class certification.

Related Party Transactions

• Recognized revenue totaling $301,000 for the three months ended October 31, 2025, and $762,000 for the nine months ended October 31, 2025, from a pharmaceutical company for advertisements.
• One of the company's independent board members serves on the board of directors for this pharmaceutical company.
• Accounts receivable from this pharmaceutical company totaled $361,000 as of October 31, 2025.

Stakeholder Impact

• Shareholders: Potential for increased value due to improved financial performance and strategic acquisition, but also dilution risk from future capital raises and stock price volatility. Anti-takeover provisions may limit influence.
• Employees: Continued growth and acquisitions may create opportunities, but also strain due to rapid expansion and remote work challenges. Stock-based compensation is a significant part of compensation.
• Customers (Healthcare Services Clients): Benefit from expanded solutions (AccessOne acquisition) and improved patient engagement tools, but potential for dissatisfaction if growth management or technical issues arise. Subject to changes in pricing and service terms.
• Patients: Benefit from improved health outcomes and streamlined processes through Phreesia's solutions, and access to financing solutions via AccessOne, but exposed to privacy and data security risks.
• Suppliers/Vendors: Continued reliance on third-party contractors and suppliers, creating opportunities but also risks if relationships are disrupted or performance degrades.
• Creditors: Bridge Loan and Capital One Credit Facility obligations, with covenants that must be maintained, impacting financial risk profile.

Next Steps

• Complete the initial accounting for the AccessOne business combination, including the identification and valuation of intangible assets and liabilities, to be presented in the Form 10-K for the fiscal year ending January 31, 2026.
• Refinance or replace the $110 million Bridge Loan with a long-term credit facility before its maturity on November 11, 2026.
• Continue to evaluate the impact of ASU 2023-09, ASU 2024-03, ASU 2025-01, ASU 2025-05, and ASU 2025-06 on financial statements and related disclosures.
• Perform further analysis on the estimated impact of the One Big Beautiful Bill Act (OBBBA) through year-end.
• Monitor macroeconomic and geopolitical developments and their potential impact on the business.
• Continue to invest to grow the business, including through acquisitions, building client and partner relationships, developing new solutions, and enhancing operating infrastructure.

Key Dates

Recommendation

The company has demonstrated a strong financial rebound, moving from significant net losses to profitability and generating substantial positive free cash flow. The strategic acquisition of AccessOne expands its market reach and service offerings, indicating a clear growth trajectory. While the Bridge Loan introduces short-term refinancing needs and ongoing legal proceedings pose a risk, the overall operational improvements, robust revenue growth across all segments, and increased Adjusted EBITDA suggest a positive outlook for future performance and shareholder value. The stock repurchase program also signals management confidence in the company's prospects.

Keywords

Healthcare technology, SaaS, Patient engagement, Payment processing, Network solutions, AccessOne acquisition, Q3 2025 earnings, Financial results, SEC filing, 10-Q, Medical financing, AI, Cybersecurity, Data privacy, Corporate governance, PHR